07 Apr 2015
The dti’s draft IP policy and the pharmaceutical industry
By Staff Writer
In the wake of the Department of Trade and Industry’s draft IP policy, Janusz Luterek, patent attorney and director of Hahn & Hahn, sheds light on the current patent law framework in South Africa and the impact the draft policy may have on the pharmaceutical industry should it eventually come into effect.
